JACKY CHUN: Open Payments
NPI 1164140109 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,149 in 56 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $707 · 2025 $1,149
Food & beverage: $1,149
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $207 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $150 |
| Janssen Biotech, Inc. | 8 | $148 |
| ABBVIE INC. | 5 | $101 |
| Ardelyx, Inc. | 3 | $91 |
| QOL Medical, LLC | 2 | $56 |
| GENZYME CORPORATION | 2 | $50 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
Products named: ENTYVIO, XIFAXAN, TREMFYA, DUPIXENT, IBSRELA, Sucraid, VOQUEZNA, INJECTAFER.
Industry payments across MD — which companies pay providers there.
